Subscribe

Korro Bio, Inc. (KRRO)

USD12.72 -0.56 (-4.18%)
US NASDAQ Healthcare Biotechnology
Address One Kendall Square 02139-1562
Cambridge, MA, US
CEO Ram Aiyar
IPO 2019-10-03
CIK 1703647 ISIN US5009461089

Explore sections of this company profile

Also trades on NASDAQ Capital Market · KRRO (USD) NASDAQ Global Select · FREQ (USD)
Description

Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.

News Sentiment (7d)
53 Neutral

Based on only 2 articles — low confidence

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD12.72 -0.56 (-4.18%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
175.6K
Beta
2.10
Float Shares
5.31M
Free Float %
56.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-4.90% -11.85% -9.62% -2.55% -63.53% +43.07% -28.29% -38.22% -97.73% -98.33% -98.33%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (12 ratings, all time) Buy
Price Targets & DCF
Current price
12.72
Low 10.00 -21.4%
Consensus 20.29 +59.6%
Median 22.00 +73.0%
High 30.00 +135.9%
Ratings Trend (MoM) 78% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 5 0
Hold 2 -1
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter 3
21.00
+65.2%
Last Year 9
20.11
+58.2%
All Time 14
45.43
+257.3%
Quality scores
Altman Z-Score
-2.72
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    +181.5% Q1'26: -100.0% (vs Q1'25)
  • EPS growth Biotechnology: +29.7%
    -33.2% Q1'26: +32.1% (vs Q1'25)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -1,386.8%
  • EBIT margin Biotechnology: +0.0%
    -1,366.4%
  • ROIC Biotechnology: -16.1%
    -441.8% Q1'26: -168.4% (vs Q1'25)
  • Share dilution Biotechnology: -3.4%
    +5.3% Q1'26: +23.6% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -0.52× Q1'26: -0.53× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (2.23) × ERP
WACC = 74% × Ke + 26% × Kd (4.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 12.72
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2019
actual
Dec 2020
actual
Dec 2021
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
6 Rev. Ana.
7 EPS Ana.
Dec 2027
4 Rev. Ana.
5 EPS Ana.
Dec 2028
5 Rev. Ana.
6 EPS Ana.
Dec 2029
2 Rev. Ana.
4 EPS Ana.
Dec 2030
2 Rev. Ana.
2 EPS Ana.
Revenue
28.95M
est: 32.53M (-11.0%)
36.98M
est: 35.39M (+4.5%)
14.07M
est: 45.07M (-68.8%)
2.27M
est: 6.28M (-63.8%)
6.39M
est: 5.52M (+15.8%)
2.40M
2.40M – 2.40M
-56.6% YoY
1.46M
1.46M – 1.46M
-39.0% YoY
1.80M
1.80M – 1.80M
+23.2% YoY
10.68M
10.68M – 10.68M
+493.4% YoY
38.62M
38.62M – 38.62M
+261.6% YoY
EBITDA
-17.93M
est: -4.38M (-309.5%)
-24.90M
est: -4.76M (-422.5%)
-80.07M
est: -6.07M (-1,219.4%)
-88.35M
est: -1.26M (-6,932.7%)
-83.06M
est: -1.10M (-7,423.7%)
-479.1K
-479.1K – -479.1K
+56.6% YoY
-292.2K
-292.2K – -292.2K
+39.0% YoY
-360.0K
-360.0K – -360.0K
-23.2% YoY
-2.14M
-2.14M – -2.14M
-493.4% YoY
-7.72M
-7.72M – -7.72M
-261.6% YoY
EBIT
-18.75M
est: -4.66M (-302.5%)
-26.48M
est: -5.07M (-422.5%)
-83.91M
est: -6.45M (-1,200.2%)
-91.91M
est: -1.26M (-7,216.5%)
-87.34M
est: -1.10M (-7,811.4%)
-479.1K
-479.1K – -479.1K
+56.6% YoY
-292.2K
-292.2K – -292.2K
+39.0% YoY
-360.0K
-360.0K – -360.0K
-23.2% YoY
-2.14M
-2.14M – -2.14M
-493.4% YoY
-7.72M
-7.72M – -7.72M
-261.6% YoY
Net Income
-18.75M
est: -328.57M (+94.3%)
-26.51M
est: -348.12M (+92.4%)
-84.69M
est: -751.67M (+88.7%)
-83.58M
est: -86.22M (+3.1%)
-117.26M
est: -84.47M (-38.8%)
-48.24M
-69.90M – -26.58M
+42.9% YoY
-43.52M
-67.89M – -19.15M
+9.8% YoY
-57.34M
-98.66M – -16.02M
-31.8% YoY
-56.20M
-56.20M – -56.20M
+2.0% YoY
-54.78M
-54.78M – -54.78M
+2.5% YoY
SGA
14.48M
est: 121.29M (-88.1%)
26.30M
est: 131.96M (-80.1%)
34.93M
est: 168.07M (-79.2%)
30.55M
est: 28.06M (+8.8%)
28.16M
est: 24.66M (+14.2%)
10.70M
10.70M – 10.70M
-56.6% YoY
6.53M
6.53M – 6.53M
-39.0% YoY
8.04M
8.04M – 8.04M
+23.2% YoY
47.72M
47.72M – 47.72M
+493.4% YoY
172.56M
172.56M – 172.56M
+261.6% YoY
EPS
-30.39
est: -36.83 (+17.5%)
-41.10
est: -39.02 (-5.3%)
-4.94
est: -84.26 (+94.1%)
-9.37
est: -9.25 (-1.3%)
-12.48
est: -9.03 (-38.2%)
-5.16
-7.44 – -2.83
+42.9% YoY
-5.08
-7.23 – -2.04
+1.6% YoY
-5.38
-10.50 – -1.71
-6.0% YoY
-5.98
-5.98 – -5.98
-11.2% YoY
-5.83
-5.83 – -5.83
+2.5% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-07 C 2/5 1/5 1/5 1/5 2/5 1/5 4/5
2026-05-06 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-05 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-04 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-29 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C- 1/5 1/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-82.97M
OE per share TTM
-8.40
Owner's Yield
-55.50%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
224.0%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
15
Total invested
63.8K
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
15
-72 vs prev Q
New positions
8
Closed positions
76
Increased
10
Reduced
1
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 30.3K +30.3K (+100.0%) 242.42M +242.4M (+100.0%) 0.32% +0.322 pp 0.23% +0.227 pp USD8.01 +0.0% 1 qtrs NEW
2 ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 1.14M +— (+0.0%) 9.11M -45.3M (-83.3%) 12.11% -0.001 pp 1.05% -6.183 pp USD47.71 -83.2% 9 qtrs
3 NEA MANAGEMENT COMPANY, LLC 1.09M +— (+0.0%) 8.74M -43.5M (-83.3%) 11.61% -0.001 pp 0.45% -2.421 pp USD47.70 -83.2% 9 qtrs
4 LYNX1 CAPITAL MANAGEMENT LP 677.9K +677.9K (+100.0%) 5.43M +5.4M (+100.0%) 7.22% +7.218 pp 1.10% +1.099 pp USD8.01 +0.0% 1 qtrs NEW
5 NANTAHALA CAPITAL MANAGEMENT, LLC 600.0K +600.0K (+100.0%) 4.81M +4.8M (+100.0%) 6.39% +6.389 pp 0.16% +0.159 pp USD8.01 +0.0% 1 qtrs NEW
6 VANGUARD GROUP INC 489.6K +94.0K (+23.8%) 3.92M -15.0M (-79.3%) 5.21% +1.000 pp 0.00% 0.000 pp USD35.18 -77.2% 9 qtrs
7 BLACKROCK, INC. 457.4K +10.7K (+2.4%) 3.66M -17.7M (-82.9%) 4.87% +0.113 pp 0.00% 0.000 pp USD31.94 -74.9% 6 qtrs
8 TCG CROSSOVER MANAGEMENT, LLC 416.3K +— (+0.0%) 3.33M -16.6M (-83.3%) 4.43% -0.001 pp 0.11% -0.870 pp USD47.89 -83.3% 2 qtrs
9 SIREN, L.L.C. 347.7K -71.1K (-17.0%) 2.79M -17.3M (-86.1%) 3.70% -0.758 pp 0.08% -0.702 pp USD33.42 -76.0% 6 qtrs
10 JANE STREET GROUP, LLC 315.9K +315.9K (+100.0%) 2.53M +2.5M (+100.0%) 3.36% +3.364 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
11 SUSQUEHANNA INTERNATIONAL GROUP, LLP 312.2K +312.2K (+100.0%) 2.50M +2.5M (+100.0%) 3.32% +3.324 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
12 72 INVESTMENT HOLDINGS, LLC 276.8K +— (+0.0%) 2.22M -11.0M (-83.3%) 2.95% 0.000 pp 4.38% -15.127 pp USD47.93 -83.3% 9 qtrs
13 GEODE CAPITAL MANAGEMENT, LLC 162.8K -172.0 (-0.1%) 1.30M -6.5M (-83.3%) 1.73% -0.002 pp 0.00% 0.000 pp USD37.35 -78.6% 9 qtrs
14 MILLENNIUM MANAGEMENT LLC 161.1K -99.2K (-38.1%) 1.29M -11.2M (-89.7%) 1.72% -1.057 pp 0.00% -0.005 pp USD32.83 -75.6% 8 qtrs
15 STATE STREET CORP 146.2K +21.7K (+17.4%) 1.17M -4.8M (-80.4%) 1.56% +0.230 pp 0.00% 0.000 pp USD35.60 -77.5% 9 qtrs
16 TWO SIGMA INVESTMENTS, LP 79.0K +14.5K (+22.5%) 632.7K -2.5M (-79.5%) 0.84% +0.155 pp 0.00% -0.004 pp USD24.08 -66.7% 3 qtrs
17 RENAISSANCE TECHNOLOGIES LLC 74.9K +34.5K (+85.4%) 599.9K -1.3M (-69.0%) 0.80% +0.367 pp 0.00% -0.002 pp USD10.43 -23.2% 3 qtrs
18 MORGAN STANLEY 69.7K -97.8K (-58.4%) 558.5K -7.5M (-93.0%) 0.74% -1.041 pp 0.00% -0.001 pp USD35.86 -77.7% 9 qtrs
19 EMERALD MUTUAL FUND ADVISERS TRUST 65.5K +6.6K (+11.3%) 525.0K -2.3M (-81.4%) 0.70% +0.071 pp 0.03% -0.120 pp USD43.85 -81.7% 2 qtrs
20 F/M INVESTMENTS LLC 65.5K +10.3K (+18.6%) 525.0K -2.1M (-80.2%) 0.70% +0.110 pp 0.02% -0.082 pp USD41.62 -80.8% 2 qtrs
21 XTX TOPCO LTD 57.1K +57.1K (+100.0%) 457.1K +457.1K (+100.0%) 0.61% +0.608 pp 0.01% +0.012 pp USD8.01 +0.0% 1 qtrs NEW
22 NORTHERN TRUST CORP 55.6K -1.6K (-2.9%) 445.7K -2.3M (-83.8%) 0.59% -0.018 pp 0.00% 0.000 pp USD36.13 -77.8% 9 qtrs
23 GOLDMAN SACHS GROUP INC 52.0K +36.3K (+231.3%) 416.1K -334.8K (-44.6%) 0.55% +0.386 pp 0.00% +0.000 pp USD20.05 -60.0% 8 qtrs
24 GRAHAM CAPITAL MANAGEMENT, L.P. 40.8K +40.8K (+100.0%) 326.5K +326.5K (+100.0%) 0.43% +0.434 pp 0.01% +0.008 pp USD8.01 +0.0% 1 qtrs NEW
25 AQR CAPITAL MANAGEMENT LLC 40.6K -7.8K (-16.0%) 325.6K -2.0M (-86.0%) 0.43% -0.083 pp 0.00% -0.001 pp USD47.89 -83.3% 2 qtrs
26 FMR LLC 37.9K -525.8K (-93.3%) 303.2K -26.7M (-98.9%) 0.40% -5.600 pp 0.00% -0.001 pp USD46.90 -82.9% 9 qtrs
27 ACADIAN ASSET MANAGEMENT LLC 33.8K +33.8K (+100.0%) 270.0K +270.0K (+100.0%) 0.36% +0.360 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
28 SIMPLEX TRADING, LLC 28.2K +28.2K (+100.0%) 226.3K +226.3K (+100.0%) 0.30% +0.301 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
29 QUANTINNO CAPITAL MANAGEMENT LP 27.6K +21.5K (+349.2%) 221.1K -73.1K (-24.9%) 0.29% +0.228 pp 0.00% 0.000 pp USD16.89 -52.6% 2 qtrs
30 ALGERT GLOBAL LLC 27.1K +20.0K (+280.8%) 217.0K -123.0K (-36.2%) 0.29% +0.213 pp 0.00% -0.002 pp USD18.48 -56.7% 2 qtrs
31 QUADRATURE CAPITAL LTD 27.1K +27.1K (+100.0%) 216.8K +216.8K (+100.0%) 0.29% +0.288 pp 0.00% +0.002 pp USD8.01 +0.0% 1 qtrs NEW
32 ENGINEERS GATE MANAGER LP 26.9K +26.9K (+100.0%) 215.3K +215.3K (+100.0%) 0.29% +0.286 pp 0.00% +0.003 pp USD8.01 +0.0% 1 qtrs NEW
33 RAYMOND JAMES FINANCIAL INC 23.0K -125.9K (-84.5%) 184.5K -6.9M (-97.4%) 0.25% -1.341 pp 0.00% -0.002 pp USD30.11 -73.4% 5 qtrs
34 UBS GROUP AG 20.0K -33.1K (-62.3%) 160.2K -2.4M (-93.7%) 0.21% -0.353 pp 0.00% 0.000 pp USD44.15 -81.9% 9 qtrs
35 MARSHALL WACE, LLP 19.8K +19.8K (+100.0%) 158.4K +158.4K (+100.0%) 0.21% +0.211 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
36 BANK OF NEW YORK MELLON CORP 18.9K -458.0 (-2.4%) 151.0K -773.9K (-83.7%) 0.20% -0.005 pp 0.00% 0.000 pp USD34.39 -76.7% 7 qtrs
37 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 16.3K -6.8K (-29.3%) 130.8K -975.5K (-88.2%) 0.17% -0.072 pp 0.00% 0.000 pp USD43.91 -81.8% 8 qtrs
38 CITADEL ADVISORS LLC 14.7K +14.7K (+100.0%) 117.7K +117.7K (+100.0%) 0.16% +0.157 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
39 DEUTSCHE BANK AG\ 12.8K +9.0K (+241.9%) 102.2K -76.5K (-42.8%) 0.14% +0.096 pp 0.00% +0.000 pp USD15.87 -49.5% 6 qtrs
40 TWO SIGMA ADVISERS, LP 11.2K -172.0 (-1.5%) 90.0K -456.4K (-83.5%) 0.12% -0.002 pp 0.00% -0.001 pp USD47.89 -83.3% 2 qtrs
41 AMERICAN CENTURY COMPANIES INC 10.6K +1.8K (+20.9%) 84.8K -334.5K (-79.8%) 0.11% +0.020 pp 0.00% 0.000 pp USD40.99 -80.5% 2 qtrs
42 JAIN GLOBAL LLC 10.6K +10.6K (+100.0%) 84.7K +84.7K (+100.0%) 0.11% +0.113 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
43 GUGGENHEIM CAPITAL LLC 10.4K +10.4K (+100.0%) 83.6K +83.6K (+100.0%) 0.11% +0.111 pp 0.00% +0.001 pp USD8.01 +0.0% 1 qtrs NEW
44 RHUMBLINE ADVISERS 10.3K +907.0 (+9.7%) 82.1K -365.3K (-81.7%) 0.11% +0.010 pp 0.00% 0.000 pp USD30.90 -74.1% 7 qtrs
45 QUEST PARTNERS LLC 7.7K +5.2K (+212.1%) 61.7K -56.5K (-47.8%) 0.08% +0.056 pp 0.00% -0.004 pp USD10.42 -23.1% 7 qtrs
46 WELLS FARGO & COMPANY/MN 7.5K +2.4K (+45.5%) 60.3K -187.3K (-75.7%) 0.08% +0.025 pp 0.00% +0.000 pp USD25.48 -68.6% 9 qtrs
47 BANK OF AMERICA CORP /DE/ 5.9K +1.2K (+25.3%) 47.2K -178.0K (-79.0%) 0.06% +0.013 pp 0.00% +0.000 pp USD16.23 -50.6% 9 qtrs
48 GROUP ONE TRADING, L.P. 4.0K +4.0K (+100.0%) 32.0K +32.0K (+100.0%) 0.04% +0.043 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
49 MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 3.1K +8.0 (+0.3%) 25.2K -125.1K (-83.2%) 0.03% +0.000 pp 0.00% 0.000 pp USD32.87 -75.6% 6 qtrs
50 NEW YORK STATE COMMON RETIREMENT FUND 3.0K +— (+0.0%) 24.0K -119.6K (-83.3%) 0.03% +0.000 pp 0.00% 0.000 pp USD33.85 -76.3% 7 qtrs
51 JPMORGAN CHASE & CO 2.8K -196.4K (-98.6%) 22.7K -9.5M (-99.8%) 0.03% -2.092 pp 0.00% -0.001 pp USD47.80 -83.2% 9 qtrs
52 RUSSELL INVESTMENTS GROUP, LTD. 1.9K +1.1K (+136.8%) 15.5K -23.6K (-60.4%) 0.02% +0.012 pp 0.00% +0.000 pp USD24.85 -67.8% 2 qtrs
53 NORTH STAR INVESTMENT MANAGEMENT CORP. 1.8K +— (+0.0%) 14.4K -71.8K (-83.3%) 0.02% +0.000 pp 0.00% -0.005 pp USD39.64 -79.8% 9 qtrs
54 STEWARD PARTNERS INVESTMENT ADVISORY, LLC 1.5K -250.0 (-14.3%) 12.0K -71.8K (-85.7%) 0.02% -0.003 pp 0.00% 0.000 pp USD32.95 -75.7% 5 qtrs
55 BNP PARIBAS ARBITRAGE, SNC 1.5K +173.0 (+13.2%) 11.9K -51.0K (-81.1%) 0.02% +0.002 pp 0.00% +0.000 pp USD33.31 -76.0% 7 qtrs
56 ADVISOR GROUP HOLDINGS, INC. 1.4K +1.1K (+406.1%) 11.3K -635.0 (-5.3%) 0.02% +0.012 pp 0.00% +0.000 pp USD15.89 -49.6% 9 qtrs
57 TOWER RESEARCH CAPITAL LLC (TRC) 1.4K +353.0 (+34.0%) 11.1K -38.6K (-77.6%) 0.01% +0.004 pp 0.00% -0.001 pp USD13.61 -41.1% 9 qtrs
58 POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 1.4K -913.0 (-39.9%) 11.0K -98.5K (-90.0%) 0.01% -0.010 pp 0.00% -0.001 pp USD42.62 -81.2% 5 qtrs
59 TD WATERHOUSE CANADA INC. 800.00 +800.0 (+100.0%) 6.4K +6.4K (+100.0%) 0.01% +0.009 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
60 PNC FINANCIAL SERVICES GROUP, INC. 740.00 -2.2K (-74.6%) 5.9K -133.6K (-95.8%) 0.01% -0.023 pp 0.00% 0.000 pp USD47.89 -83.3% 2 qtrs
61 CITIGROUP INC 607.00 +270.0 (+80.1%) 4.9K -11.3K (-69.9%) 0.01% +0.003 pp 0.00% +0.000 pp USD25.31 -68.4% 9 qtrs
62 AMERITAS INVESTMENT PARTNERS, INC. 598.00 +— (+0.0%) 4.8K -23.8K (-83.3%) 0.01% +0.000 pp 0.00% -0.001 pp USD33.85 -76.3% 7 qtrs
63 LEGAL & GENERAL GROUP PLC 526.00 +— (+0.0%) 4.2K -21.0K (-83.3%) 0.01% +0.000 pp 0.00% +0.000 pp USD37.52 -78.7% 7 qtrs
64 LOS ANGELES CAPITAL MANAGEMENT LLC 110.00 +110.0 (+100.0%) 4.0K +4.0K (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
65 STERLING CAPITAL MANAGEMENT LLC 458.00 +— (+0.0%) 3.7K -18.3K (-83.3%) 0.00% +0.000 pp 0.00% 0.000 pp USD43.02 -81.4% 6 qtrs
66 DUNCKER STREETT & CO INC 437.00 +— (+0.0%) 3.5K -17.4K (-83.3%) 0.00% +0.000 pp 0.00% -0.003 pp USD47.93 -83.3% 9 qtrs
67 CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 408.00 -8.0 (-1.9%) 3.3K -16.7K (-83.6%) 0.00% 0.000 pp 0.00% +0.000 pp USD37.68 -78.7% 7 qtrs
68 FEDERATED HERMES, INC. 302.00 +302.0 (+100.0%) 2.4K +2.4K (+100.0%) 0.00% +0.003 pp 0.00% +0.000 pp USD8.01 +0.0% 1 qtrs NEW
69 CWM, LLC 288.00 -2.4K (-89.3%) 2.0K -127.0K (-98.4%) 0.00% -0.026 pp 0.00% 0.000 pp USD40.76 -80.3% 4 qtrs
70 AMALGAMATED BANK 208.00 -3.0 (-1.4%) 2.0K -8.0K (-80.0%) 0.00% +0.000 pp 0.00% 0.000 pp USD33.85 -76.3% 7 qtrs
71 ROYAL BANK OF CANADA 224.00 -5.8K (-96.3%) 2.0K -285.0K (-99.3%) 0.00% -0.061 pp 0.00% +0.000 pp USD35.92 -77.7% 9 qtrs
72 OPTIVER HOLDING B.V. 116.00 +— (+0.0%) 929.00 -4.6K (-83.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD47.89 -83.3% 2 qtrs
73 GAMMA INVESTING LLC 102.00 +13.0 (+14.6%) 817.00 -3.4K (-80.8%) 0.00% +0.000 pp 0.00% 0.000 pp USD23.24 -65.5% 6 qtrs
74 UBS ASSET MANAGEMENT AMERICAS INC 91.00 +91.0 (+100.0%) 729.00 +729.0 (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD8.00 +0.1% 1 qtrs NEW
75 IFP ADVISORS, INC 40.00 +— (+0.0%) 320.00 -1.6K (-83.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD47.88 -83.3% 2 qtrs
76 GLOBAL RETIREMENT PARTNERS, LLC 35.00 +35.0 (+100.0%) 280.00 +280.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.00 +0.1% 1 qtrs NEW
77 ROTHSCHILD INVESTMENT LLC 6.00 +6.0 (+100.0%) 48.00 +48.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.00 +0.1% 1 qtrs NEW
78 MAI CAPITAL MANAGEMENT 5.00 +— (+0.0%) 41.00 -199.0 (-82.9%) 0.00% +0.000 pp 0.00% +0.000 pp USD38.00 -78.9% 5 qtrs
79 NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 2.00 +— (+0.0%) 16.00 -80.0 (-83.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD12.00 -33.3% 3 qtrs
80 ALLWORTH FINANCIAL LP 1.00 -91.0 (-98.9%) 9.00 -4.4K (-99.8%) 0.00% -0.001 pp 0.00% +0.000 pp USD47.00 -83.0% 2 qtrs
81 SBI SECURITIES CO., LTD. 1.00 +— (+0.0%) 8.00 -40.0 (-83.3%) 0.00% +0.000 pp 0.00% +0.000 pp USD38.00 -78.9% 5 qtrs
82 SUNBELT SECURITIES, INC. 1.00 +1.0 (+100.0%) 8.00 +8.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.00 +0.1% 1 qtrs NEW
83 ADAR1 CAPITAL MANAGEMENT, LLC -40.2K (-100.0%) -1.9M (-100.0%) 0.00% -0.429 pp 0.00% -0.181 pp USD 7 qtrs SOLD
84 POINT72 ASSET MANAGEMENT, L.P. -532.0K (-100.0%) -25.5M (-100.0%) 0.00% -5.665 pp 0.00% -0.043 pp USD 9 qtrs SOLD
85 POLAR CAPITAL HOLDINGS PLC -264.7K (-100.0%) -12.7M (-100.0%) 0.00% -2.819 pp 0.00% -0.061 pp USD 5 qtrs SOLD
86 NUVEEN, LLC -9.3K (-100.0%) -443.7K (-100.0%) 0.00% -0.099 pp 0.00% 0.000 pp USD 4 qtrs SOLD
87 QUARRY LP -4.4K (-100.0%) -209.5K (-100.0%) 0.00% -0.047 pp 0.00% -0.046 pp USD 8 qtrs SOLD
88 METLIFE INVESTMENT MANAGEMENT, LLC -3.9K (-100.0%) -188.9K (-100.0%) 0.00% -0.042 pp 0.00% -0.001 pp USD 7 qtrs SOLD
89 CLEARSTEAD ADVISORS, LLC -18.0 (-100.0%) -863.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
90 TRUE WEALTH DESIGN, LLC -19.0 (-100.0%) -910.0 (-100.0%) 0.00% 0.000 pp 0.00% 0.000 pp USD 4 qtrs SOLD
91 BLUE OWL CAPITAL HOLDINGS LP -105.0K (-100.0%) -5.0M (-100.0%) 0.00% -1.118 pp 0.00% -1.561 pp USD 3 qtrs SOLD
92 BLAIR WILLIAM & CO/IL -9.8K (-100.0%) -466.9K (-100.0%) 0.00% -0.104 pp 0.00% -0.001 pp USD 6 qtrs SOLD
93 WEALTH FORWARD, LLC -5.0K (-100.0%) -239.9K (-100.0%) 0.00% -0.053 pp 0.00% -0.139 pp USD 2 qtrs SOLD
94 ALLIANCEBERNSTEIN L.P. -7.7K (-100.0%) -368.8K (-100.0%) 0.00% -0.082 pp 0.00% 0.000 pp USD 5 qtrs SOLD
95 ORBIMED ADVISORS LLC -32.4K (-100.0%) -1.6M (-100.0%) 0.00% -0.345 pp 0.00% -0.037 pp USD 5 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 57 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 F/M Emerald Life Sciences Innovation ETF LFSC 0.74% 553.5K 0.54%
2 iShares Micro-Cap ETF IWC 0.04% 544.5K 0.60%
3 Invesco Russell 2000 Dynamic Multifactor ETF OMFS 0.01% 30.9K 0.39%
4 iShares Russell 2000 Value ETF IWN 0.01% 1.19M 0.24%
5 State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L 0.01% 334.0K 0.30%
6 iShares Russell 2000 Growth ETF IWO 0.01% 888.4K 0.24%
7 iShares Russell 2000 BuyWrite ETF IWMW 0.01% 2.9K 0.39%
8 Global X - Russell 2000 ETF RSSL 0.01% 75.8K 0.08%
9 iShares Russell 2000 ETF IWM 0.01% 4.26M 0.19%
10 Invesco Russell 2000 UCITS ETF RTYS.L 0.01% 16.4K 0.25%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
27
Sells
0
Shares acquired
4.73M
Shares disposed
Cash buys
19.00
Cash sales
Net activity
+4,731,970
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-03-31 Lynx1 Capital Management LP 10% Owner P-Purchase A Common stock, $0.001 par value per share 520 10.60 5.5K 1,538,296 I
2026-03-10 Yang Rick 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 Walker Paul Edward 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 SANDELL SCOTT D 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 New Enterprise Associates 17, L.P. 10% Owner P-Purchase A Common Stock 207,100 11.11 2.30M 1,297,893 D
2026-03-10 Mathers Edward T 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 Makhzoumi Mohamad 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 Florence Anthony A. Jr. 10% Owner P-Purchase A Common Stock 207,100 11.11 2.30M 1,297,893 I
2026-03-10 Chang Carmen 10% Owner P-Purchase A Common Stock 207,100 11.11 2.30M 1,297,893 I
2026-03-10 Behbahani Ali Director / 10% Owner A-Award A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-03-10 BASKETT FOREST 10% Owner P-Purchase A Pre-Funded Warrants 242,945 0.00 242.95 242,945 I
2026-02-02 Vincent Loic A Officer A-Award A Stock Option (Right to Buy) 35,000 13.05 456.8K 35,000 D
2026-02-02 Dolan Oliver Officer A-Award A Stock Option (Right to Buy) 15,000 13.05 195.8K 15,000 D
2026-02-02 Chappell Todd Officer A-Award A Stock Option (Right to Buy) 38,000 13.05 495.9K 38,000 D
2026-02-02 Cerio Jeffrey Officer A-Award A Stock Option (Right to Buy) 23,000 13.05 300.2K 23,000 D
2026-02-02 Aiyar Ram Director / Officer A-Award A Stock Option (Right to Buy) 80,000 13.05 1.04M 80,000 D
2025-12-15 Vincent Loic A Officer A-Award A Common Stock 21,715 0.00 21,715 D
2025-12-15 Dolan Oliver Officer A-Award A Common Stock 21,482 0.00 21,482 D
2025-12-15 Chappell Todd Officer A-Award A Common Stock 20,132 0.00 20,132 D
2025-12-15 Cerio Jeffrey Officer A-Award A Common Stock 41,902 0.00 41,902 D
2025-06-11 PEARSON TIMOTHY R Director A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-06-11 Meyers Rachel Director A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-06-11 Knobil Katharine Director A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-06-11 FORMELA JEAN FRANCOIS Director A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-06-11 Bermingham Nessan Director A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-06-11 Behbahani Ali Director / 10% Owner A-Award A Stock Option (Right to Buy) 6,010 14.87 89.4K 6,010 D
2025-04-01 Vincent Loic A Officer A-Award A Stock Option (Right to Buy) 70,000 15.95 1.12M 70,000 D
2025-04-01 Dolan Oliver Officer A-Award A Stock Option (Right to Buy) 20,000 15.95 319.0K 20,000 D
2025-03-31 Vincent Loic A 0 0.00 0
2025-02-11 Dolan Oliver Officer Stock Option (Right to Buy) 15,000 42.99 644.9K 0 D
2025-02-03 Olugemo Olukemi Officer A-Award A Stock Option (Right to Buy) 42,000 33.50 1.41M 42,000 D
2025-02-03 Chappell Todd Officer A-Award A Stock Option (Right to Buy) 34,500 33.50 1.16M 34,500 D
2025-02-03 Cerio Jeffrey Officer A-Award A Stock Option (Right to Buy) 29,000 33.50 971.5K 29,000 D
2025-02-03 Aiyar Ram Director / Officer A-Award A Stock Option (Right to Buy) 100,000 33.50 3.35M 100,000 D
2025-02-03 Agarwal Vineet Officer A-Award A Stock Option (Right to Buy) 30,000 33.50 1.01M 30,000 D
2024-11-11 Agarwal Vineet Officer M-Exempt D Stock Option (Right to Buy) 800 11.68 9.3K 30,807 D
2024-10-17 Agarwal Vineet Officer S-Sale D Common Stock 164 73.71 12.1K 8,029 D
2024-09-03 Cerio Jeffrey Officer A-Award A Stock Option (Right to Buy) 40,000 44.37 1.77M 40,000
2024-08-30 Cerio Jeffrey 0 0.00 0
2024-08-26 Knobil Katharine 0 0.00 0
2024-06-11 PEARSON TIMOTHY R Director A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-11 Meyers Rachel Director A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-11 Lucchino David L. Director A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-11 FORMELA JEAN FRANCOIS Director A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-11 Bermingham Nessan Director A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-11 Behbahani Ali Director / 10% Owner A-Award A Stock Option (Right to Buy) 5,190 42.19 219.0K 5,190
2024-06-03 Olugemo Olukemi Officer A-Award A Stock Option (Right to Buy) 65,000 50.48 3.28M 65,000
2024-05-13 Olugemo Olukemi 0 0.00 0
2024-04-22 Yang Rick 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Walker Paul Edward 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 SANDELL SCOTT D 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 New Enterprise Associates 17, L.P. 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Mathers Edward T 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Makhzoumi Mohamad 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Florence Anthony A. Jr. 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 FORMELA JEAN FRANCOIS Director A-Award A Common Stock 17,857 56.00 1,000.0K 195,074
2024-04-22 Chang Carmen 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Behbahani Ali Director / 10% Owner A-Award A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 BASKETT FOREST 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 1,090,793
2024-04-22 Atlas Venture Opportunity Fund II, L.P. 10% Owner P-Purchase A Common Stock 17,857 56.00 1,000.0K 195,074
2023-11-03 Atlas Venture Opportunity Fund II, L.P. 10% Owner I Common Stock 0 0.00 942,075

Executive team

Top executives
EBIT / Employee
-7.8K
Shares Outstanding
9.40M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2025-04-29 DEFA14A
2025-04-29 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-07 8-K
2026-05-07 10-Q
2026-04-16 DEFA14A
2026-04-16 DEF 14A
2026-04-16 ARS
2026-04-02 SC 13G/A
2026-04-02 4
2026-04-02 3
2026-03-27 SC 13G/A
2026-03-20 EFFECT

Executive team

NameTitleCompensationGender
Ram Aiyar Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director 852.7K male
Loic Vincent Chief Scientific Officer 642.5K
Jeffrey Cerio Senior Vice President, General Counsel & Corporate Secretary 587.5K male
Oliver Dolan Senior Vice President of Finance & Principal Accounting Officer male
Stephanie Engels Chief People Officer female
Andrew Fraley Co-Founder & Advisor male
Todd Chappell Chief Operating Officer male
Gaozhong Zhu SVP of Chemistry, Manufacturing and Controls & Technical Operations
Joshua Rosenthal Co-Founder & Advisor
ESG Rating
B
BIOTECHNOLOGY
2026
E (Environmental)
56.6 / 56.3
Company / Sector avg.
S (Social)
60.6 / 62.4
Company / Sector avg.
G (Governance)
55.6 / 60.9
Company / Sector avg.
ESG Total
57.6 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits